Canada

February 11, 2015November 9, 2015

AstraZeneca Acquires Rights To Actavis’ Branded COPD Portfolio in Canada and US

COPD, News

Actavis and AstraZeneca have recently announced signing a new agreement assuring that AstraZeneca will acquire the rights to Actavis’ respiratory portfolio in both Canada and the United States for an upfront payment worth $600 million upon completion, ... Read more

February 9, 2015November 9, 2015

Novartis’ Ultibro Breezhaler For COPD Now Available In Quebec

COPD, News

After being recently launched in the UK, the Ultibro® Breezhaler® has been added to the list of medications recognized by the Régie de l’assurance malady du Québec (RAMQ) as a “Médicament d’exception,” and is ... Read more

December 15, 2014November 6, 2015

Enrollment Ongoing for Canadian Study on Asthma Treatment Compliance

Asthma, News

One of the challenges asthma patients face is medication compliance, as many require long-term or even lifelong treatment and maintenance. Oftentimes, these medications would successfully induce remission, which would prompt ... Read more

November 14, 2014November 5, 2015

Study Quantifies Canadian CF Patients’ Increased Longevity, Identifies Key Risk Factors

Cystic Fibrosis, News

Recently, several reports out of Canada have revealed that Cystic Fibrosis patients there are leading increasingly longer, healthier lives than in other nations with high CF patient populations. Now, a ... Read more